The product consists of 95 % maltodextrin α-glucan which is enzymatically produced from starch. Various types of starches can be used as starting material for this .alpha.-glycosyl transferase-catalyzed process. The product is claimed to have a beneficial effect on the intestinal flora and will be marketed from November 2015.

Hayashibara news release, September 28, 2015